Manulife (Manufacturers Life Insurance)
GH icon

Manulife (Manufacturers Life Insurance)’s Guardant Health GH Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$209M Buy
1,390,337
+184,636
+15% +$20.1M 0.16% 123
2026
Q1 		$111M Buy
1,205,701
+569,766
+90% +$57.2M 0.1% 202
2025
Q4 		$64.8M Buy
635,935
+1,484
+0.2% +$133K 0.05% 295
2025
Q3 		$39.6M Buy
634,451
+1,821
+0.3% +$99.1K 0.03% 448
2025
Q2 		$32.9M Buy
632,630
+54,284
+9% +$2.42M 0.03% 478
2025
Q1 		$24.6M Buy
578,346
+95,458
+20% +$4.12M 0.02% 550
2024
Q4 		$14.8M Sell
482,888
-1,649
-0.3% -$46.4K 0.01% 721
2024
Q3 		$11.1M Sell
484,537
-28,746
-6% -$814K 0.01% 849
2024
Q2 		$14.8M Sell
513,283
-19,219
-4% -$448K 0.01% 698
2024
Q1 		$11M Buy
532,502
+2,786
+0.5% +$59.7K 0.01% 810
2023
Q4 		$14.3M Sell
529,716
-38,432
-7% -$1.01M 0.01% 721
2023
Q3 		$16.8M Buy
568,148
+16,111
+3% +$567K 0.01% 637
2023
Q2 		$19.8M Buy
552,037
+65,846
+14% +$1.89M 0.01% 602
2023
Q1 		$11.4M Buy
486,191
+157,489
+48% +$4.5M 0.01% 754
2022
Q4 		$8.93M Buy
328,702
+4,544
+1% +$208K 0.01% 830
2022
Q3 		$17.4M Buy
324,158
+7,593
+2% +$390K 0.01% 627
2022
Q2 		$12.9M Buy
316,565
+12,117
+4% +$600K 0.01% 737
2022
Q1 		$20.2M Buy
304,448
+40,985
+16% +$2.8M 0.01% 663
2021
Q4 		$26.4M Sell
263,463
-86,567
-25% -$8.95M 0.02% 557
2021
Q3 		$43.8M Hold
350,030
– – 0.04% 410
2021
Q2 		$43.5M Buy
350,030
+36,207
+12% +$4.87M 0.04% 407
2021
Q1 		$47.9M Sell
313,823
-2,523
-0.8% -$381K 0.04% 381
2020
Q4 		$40.8M Hold
316,346
– – 0.04% 383
2020
Q3 		$35.4M Buy
316,346
+1,967
+0.6% +$180K 0.04% 387
2020
Q2 		$25.1M Hold
314,379
– – 0.02% 464
2020
Q1 		$21.9M Hold
314,379
– – 0.02% 458
2019
Q4 		$24.6M Buy
+314,379
New +$22.7M 0.03% 494
2019
Q2 		– Sell
-10,591
Closed -$812K – 2925
2019
Q1 		$812K Buy
+10,591
New +$587K ﹤0.01% 1817

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s GH Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Guardant Health (GH) stake by 15% in Q2 2026, buying an estimated $20.1M and bringing the position to 1,390,337 shares worth $209M. The position accounts for 0.16% of the portfolio, ranked #123.

Manulife (Manufacturers Life Insurance) first reported a position in GH in Q1 2019 and has held it in 28 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 1,390,337 shares of Guardant Health worth $209M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) bought 184,636 Guardant Health shares in Q2 2026, an estimated $20.1M.
  • Guardant Health made up 0.16% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #123 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Guardant Health in Q1 2019 and has held it in 28 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.